EYP-1901

· EyePoint Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for EYP-1901, covering 2025-03-04 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME [Phase 3]

See pricing